LENZ Therapeutics LENZ
NASDAQ LENZ
$3.58 -0.21 (-5.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Selling, General & Administrative (2020 - 2026)

Updated

LENZ Therapeutics' Selling, General & Administrative was $39.38 million in Q2 2026, up 207.7% from $12.8 million a year earlier but down 12.4% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, LENZ Therapeutics' Selling, General & Administrative was $151.57 million through Jun 30, 2026, up 281.2% year-over-year; for FY2025, it came in at $91.14 million, up 216.4% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 83.5% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $28.81 million in FY2024 (+122.9%), $12.93 million in FY2023 (-60.7%), $32.85 million in FY2022 (+45.9%) and $22.51 million in FY2021 (+414.3%).
  • Quarterly Selling, General & Administrative has moved between $2.29 million (Q1 2023) and $44.96 million (Q1 2026) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for ten straight quarters, with growth averaging 191.5% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2025 (growth of 324.9%); the worst was Q2 2023 (a decline of 74.2%).
  • Per Business Quant data, LENZ's Selling, General & Administrative in the three quarters before Q2 2026 was $44.96 million (Q1 2026), $39.63 million (Q4 2025) and $27.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 LENZ Therapeutics 112.47 Mn 112.47 Mn 5.21 Mn 39.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.38 Mn
Mar 31, 2026 44.96 Mn
Dec 31, 2025 39.63 Mn
Sep 30, 2025 27.60 Mn
Jun 30, 2025 12.80 Mn
Mar 31, 2025 11.11 Mn
Dec 31, 2024 9.36 Mn
Sep 30, 2024 6.49 Mn
Jun 30, 2024 7.41 Mn
Mar 31, 2024 5.55 Mn
Dec 31, 2023 5.45 Mn
Sep 30, 2023 2.86 Mn
Jun 30, 2023 2.32 Mn
Mar 31, 2023 2.29 Mn
Dec 31, 2022 8.29 Mn
Sep 30, 2022 7.85 Mn
Jun 30, 2022 9.00 Mn
Mar 31, 2022 7.71 Mn
Dec 31, 2021 7.74 Mn
Sep 30, 2021 5.92 Mn
API Access

LENZ Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LENZ&period=max&api_key=YOUR_API_KEY